Abstracts - faqs.org

Abstracts

Pharmaceuticals and cosmetics industries

Search abstracts:
Abstracts » Pharmaceuticals and cosmetics industries

Modulation of platelet aggregation by an L-arginine-nitric oxide pathway

Article Abstract:

L-arginine and nitric oxide are found to inhibit collagen-mediated blood platelet aggregation resulting in an increase in intraplatelet cGMP. This reaction is stimulated by a sudden rise in intracellular Ca2+ which leads to aggregation. The Ca2+-initiated activity generates nitric oxide from L-arginine via nitric oxide synthase reaction. The formation of nitric oxide regulates soluble guanylyl cyclase which eventually reduces the aggregation process. Moreover, agents that interfere with nitric oxide formation or limit its effects enhance the occurrence of platelet aggregation.

Author: Radomski, Marek W., Palmer, Richard M.J., Moncada, Salvador
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1991
Collagen, Blood platelets, Arginine, Cell aggregation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nitric oxide: from discovery to the clinic

Article Abstract:

Nitric oxide has indisputably been demonstrated to be an important biological entity. Among its other functions, nitric oxide has clearly been shown to act as a significant regulator of general cellular processes such as gene expression and mitochondrial function. The NOS structure continues to conceal several surprising discoveries. For example, X-ray diffraction analysis at 0.19 nm resolution has shown that eNOS is a metalloenzyme able to bind ZN with high affinity.

Author: Lamas, Santiago, Moncada, Salvador, Perez-Sala, Dolores
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1998
Cellular control mechanisms, Cell regulation

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Nitric oxide takes center-stage with newly defined roles

Article Abstract:

Studies show that nitric oxide may have potential applications in clinical medicine. Nitric oxide, which is synthesized from L-arginine by nitric oxide synthase, binds with guanylyl cyclase to activate cardiovascular and neural actions. It can also be added to intact cells to cause nitrosylation of nucleic acids and break DNA strands. Other studies also provide evidences supporting the possible role of nitric oxide in the immune system.

Author: Vallance, Patrick, McCall, Therese
Publisher: Elsevier Science Publishers
Publication Name: Trends in Pharmacological Sciences
Subject: Pharmaceuticals and cosmetics industries
ISSN: 0165-6147
Year: 1992

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Research, Nitric oxide
Similar abstracts:
  • Abstracts: On the selectivity of 7-nitroindazole as an inhibitor of neuronal nitric oxide synthase. Phosphodiesterases: the journey towards therapeutics
  • Abstracts: Clinical evaluation of 5-HT3 receptor antagonists as anti-emetics. The 5-HT(sub 4) receptor: a place in the sun
  • Abstracts: Receptor-gated ion channels may be selective CNS targets for ethanol
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.